OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HBMN55

HBM Healthcare Investments AG

Investment Management & Fund OperatorsVerified

HBM Healthcare Investments AG maintains a capital structure with a low debt-to-equity ratio of 0.06, indicating a conservative leverage profile. However, the company's liquidity position is assessed as medium, with a current ratio of 0.81, suggesting that its current liabilities exceed its current assets. The negative net cash position, after subtracting total debt, further highlights potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 1.13%, and its return on assets (ROA) is 1.06%, both of which are below the typical thresholds for strong performance in the investment management industry. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in the healthcare sector, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as regulatory changes or market volatility in the healthcare industry. Looking at the growth trajectory, the company's recent financial performance shows a net income of CHF 18.54 million, but its operating cash flow is negative at CHF -2.36 million. This discrepancy may indicate that the company is reinvesting in its operations or facing temporary cash flow challenges. The outlook for the current fiscal year is not explicitly provided, but the negative operating cash flow suggests caution in forecasting near-term growth. The risk assessment indicates a low potential for dilution, with no significant dilution sources identified in the provided data. However, the company's liquidity risk is moderate, primarily due to its negative net cash position and low current ratio. Credit risk is not explicitly quantified, but the low leverage profile suggests a relatively stable credit position. Recent events, such as filings and transcripts, are not detailed in the provided data. However, the company's financial snapshot indicates a need for careful monitoring of its liquidity and cash flow management to ensure long-term stability.

30-day price · HBMN+7.00 (+3.0%)
Low$224.00High$239.50Close$238.50As of28 May, 00:00 UTC
Profile
CompanyHBM Healthcare Investments AG
TickerHBMN.S
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. HBM Healthcare Investments AG is an investment management company that primarily invests in the healthcare sector, generating revenue through capital appreciation and dividend income from its portfolio of healthcare-related assets.

Classification. HBM Healthcare Investments AG is classified under the Financials sector, specifically in the Investment Management & Fund Operators industry, with a high confidence level of 0.92 based on verified market data.

HBM Healthcare Investments AG maintains a capital structure with a low debt-to-equity ratio of 0.06, indicating a conservative leverage profile. However, the company's liquidity position is assessed as medium, with a current ratio of 0.81, suggesting that its current liabilities exceed its current assets. The negative net cash position, after subtracting total debt, further highlights potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 1.13%, and its return on assets (ROA) is 1.06%, both of which are below the typical thresholds for strong performance in the investment management industry. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in the healthcare sector, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as regulatory changes or market volatility in the healthcare industry. Looking at the growth trajectory, the company's recent financial performance shows a net income of CHF 18.54 million, but its operating cash flow is negative at CHF -2.36 million. This discrepancy may indicate that the company is reinvesting in its operations or facing temporary cash flow challenges. The outlook for the current fiscal year is not explicitly provided, but the negative operating cash flow suggests caution in forecasting near-term growth. The risk assessment indicates a low potential for dilution, with no significant dilution sources identified in the provided data. However, the company's liquidity risk is moderate, primarily due to its negative net cash position and low current ratio. Credit risk is not explicitly quantified, but the low leverage profile suggests a relatively stable credit position. Recent events, such as filings and transcripts, are not detailed in the provided data. However, the company's financial snapshot indicates a need for careful monitoring of its liquidity and cash flow management to ensure long-term stability.
Key takeaways
  • HBM Healthcare Investments AG has a conservative capital structure with a low debt-to-equity ratio of 0.06.
  • The company's return on equity and return on assets are below typical performance thresholds for the investment management industry.
  • Revenue is concentrated in the healthcare sector, with no geographic diversification disclosed.
  • The company's liquidity position is medium, with a current ratio of 0.81 and a negative net cash position.
  • There is a low potential for dilution, but liquidity risk remains a concern due to the negative operating cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCHF
Revenue$42.0M
Gross profit$19.5M
Operating income$19.8M
Net income$18.5M
R&D
SG&A
D&A
SBC
Operating cash flow-$2.4M
CapEx
Free cash flow
Total assets$1.75B
Total liabilities$102.7M
Total equity$1.65B
Cash & equivalents$2.5M
Long-term debt$99.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.65B
Net cash-$97.1M
Current ratio0.8
Debt/Equity0.1
ROA1.1%
ROE1.1%
Cash conversion-13.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricHBMNActivity
Op margin47.2%25.7% medp25 3.6% · p75 52.2%above median
Net margin44.1%21.2% medp25 4.2% · p75 45.9%above median
Gross margin46.4%81.4% medp25 46.5% · p75 95.8%bottom quartile
CapEx / revenue-1.7% medp25 -4.8% · p75 -0.4%
Debt / equity6.0%14.8% medp25 0.1% · p75 134.4%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 18:01 UTC#cf7ee600
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 02:39 UTCJob: fa378ea0